Menopausal hormone therapy and breast cancer: risk and management
Most healthy women can use hormone therapy safely with individualized counseling, attention to timing, and progestogen selection. Among survivors, low-dose vaginal estrogen remains appropriate for refractory GSM with oncology involvement.
Authors
- Kathryne A. Sanserino
Institutions
- Stanford University (US)
Publication Details
- Journal
- Current Opinion in Obstetrics & Gynecology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1097/gco.0000000000001094
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00